USD 0.0
(0.0%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|
Operating Cash Flow | -3.89 Million | -4.75 Million | -2.96 Million | -12.26 Million | -4.16 Million | -1.87 Million |
Net Income | -5.14 Million | -7.26 Million | -7.59 Million | -11.14 Million | -3.83 Million | -2.45 Million |
Depreciation & Amortization | 459.07 Thousand | 499 Thousand | 760.31 Thousand | 485.22 Thousand | 274.19 Thousand | 232.72 Thousand |
Deferred income taxes | - | 1.45 Million | -2.24 Million | - | -598.91 Thousand | - |
Stock-based compensation | 112.34 Thousand | 214.15 Thousand | 2.02 Million | 2.38 Million | 1.27 Million | 194.19 Thousand |
Change in working capital | 501.51 Thousand | 279.17 Thousand | 1.83 Million | -3.99 Million | -1.33 Million | -664.32 Thousand |
Other non-cash items | 179.02 Thousand | 57.44 Thousand | 2.24 Million | 2207.00 | 60.66 Thousand | 818.59 Thousand |
Investing Cash Flow | 18.45 Thousand | -80.28 Thousand | -88.03 Thousand | -1.44 Million | -597.46 Thousand | -447.06 Thousand |
Investments in PPE | -10.33 Thousand | -80.28 Thousand | -88.03 Thousand | -1.44 Million | -597.46 Thousand | -447.06 Thousand |
Acquisitions | 28.79 Thousand | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 28.79 Thousand | - | - | -55 Thousand | - | - |
Financing Cash Flow | 3.44 Million | 5.21 Million | 2.08 Million | 14.62 Million | 4.89 Million | 2.25 Million |
Debt repayment | -52.99 Thousand | -707.81 Thousand | -68.11 Thousand | -262.92 Thousand | -780.15 Thousand | -12.24 Thousand |
Dividends payments | - | -195.83 Thousand | - | - | - | -41.42 Thousand |
Common Stock Repurchased | - | - | - | - | - | 1.03 Million |
Common Stock Issuance | - | 3.75 Million | 1.01 Million | 13.36 Million | 5.53 Million | 700.5 Thousand |
Other Financing Activities | 3.5 Million | 4.5 Million | 1.14 Million | 1.52 Million | 146.79 Thousand | 575.19 Thousand |
Accounts receivables | 70.32 Thousand | 281.6 Thousand | 144.77 Thousand | -278.88 Thousand | -164.24 Thousand | -79.9 Thousand |
Accounts payables | -175.54 Thousand | -472.89 Thousand | 452.99 Thousand | 1.37 Million | -55.65 Thousand | 193.43 Thousand |
Inventory | 166.86 Thousand | 688.11 Thousand | 708.47 Thousand | -4.09 Million | -1.08 Million | -882.13 Thousand |
Other working capital | 439.86 Thousand | -217.64 Thousand | 528.44 Thousand | -998.41 Thousand | -39.78 Thousand | 104.28 Thousand |
Cash at beginning of period | 481.76 Thousand | 107.69 Thousand | 1.07 Million | 164.08 Thousand | 27.8 Thousand | 95.59 Thousand |
Cash at end of period | 55.27 Thousand | 481.76 Thousand | 107.69 Thousand | 1.07 Million | 164.08 Thousand | 27.8 Thousand |
Capital Expenditure | -10.33 Thousand | -80.28 Thousand | -88.03 Thousand | -1.44 Million | -597.46 Thousand | -447.06 Thousand |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -426.49 Thousand | 374.07 Thousand | -968.85 Thousand | 912.45 Thousand | 136.28 Thousand | -67.78 Thousand |
Free Cash Flow | -3.9 Million | -4.83 Million | -3.05 Million | -13.71 Million | -4.76 Million | -2.31 Million |
Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -1.13 Million | -1.42 Million | -921.23 Thousand | -5.14 Million | -1.97 Million | -979.23 Thousand |
Depreciation & Amortization | 48.06 Thousand | 53.92 Thousand | 50.37 Thousand | 459.07 Thousand | 107.34 Thousand | 113.74 Thousand |
Deferred income taxes | -55.88 Thousand | 444.85 Thousand | - | - | - | - |
Stock-based compensation | 36.5 Thousand | 24.97 Thousand | 4820.00 | 112.34 Thousand | 8444.00 | 13.83 Thousand |
Change in working capital | 318.64 Thousand | 306.64 Thousand | 878.13 Thousand | 501.51 Thousand | 762.15 Thousand | -257.57 Thousand |
Other non-cash items | 188.49 Thousand | 83.86 Thousand | 48.57 Thousand | 179.02 Thousand | 503.66 Thousand | 37.63 Thousand |
Investing Cash Flow | 64.55 Thousand | 13.5 Thousand | - | 18.45 Thousand | -5165.00 | - |
Investments in PPE | -1.00 | - | - | -10.33 Thousand | -5265.00 | - |
Acquisitions | 64.55 Thousand | 13.5 Thousand | - | 28.79 Thousand | 100.00 | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 64.55 Thousand | 13.5 Thousand | - | 28.79 Thousand | 100.00 | - |
Financing Cash Flow | 473.31 Thousand | 248.66 Thousand | 248.05 Thousand | 3.44 Million | 530.49 Thousand | 988.75 Thousand |
Debt repayment | -26.68 Thousand | -1333.00 | -1945.00 | -52.99 Thousand | -30.49 Thousand | -988.75 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 500 Thousand | 250 Thousand | 250 Thousand | 3.5 Million | 560.99 Thousand | 1 Million |
Accounts receivables | -4784.00 | 13.8 Thousand | -2623.00 | 70.32 Thousand | 124.84 Thousand | 178.1 Thousand |
Accounts payables | 79.89 Thousand | -15.17 Thousand | -4083.00 | -175.54 Thousand | -17.01 Thousand | -100.1 Thousand |
Inventory | -6945.00 | 42.73 Thousand | 93.14 Thousand | 166.86 Thousand | 464.4 Thousand | -61.55 Thousand |
Other working capital | 250.47 Thousand | 265.28 Thousand | 791.69 Thousand | 439.86 Thousand | 189.92 Thousand | -487.45 Thousand |
Cash at beginning of period | 119.91 Thousand | 364 Thousand | 55.27 Thousand | 481.76 Thousand | 124.74 Thousand | 164.38 Thousand |
Cash at end of period | 58.78 Thousand | 119.91 Thousand | 364 Thousand | 55.27 Thousand | 55.27 Thousand | 124.74 Thousand |
Capital Expenditure | -1.00 | - | - | -10.33 Thousand | -5265.00 | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -61.12 Thousand | -244.09 Thousand | 308.73 Thousand | -426.49 Thousand | -69.47 Thousand | -39.63 Thousand |
Free Cash Flow | -599 Thousand | -506.25 Thousand | 60.67 Thousand | -3.9 Million | -600.07 Thousand | -1.02 Million |
KC
2307
GOPAL
BOVNF
AV-B
SHILPAMED